Wiley Bros. Aintree Capital, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History
Wiley Bros. Aintree Capital, LLC
- $718 Million
- Q1 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 5,479 shares of XBI stock, worth $534,257. This represents 0.07% of its overall portfolio holdings.
Number of Shares
5,479
Previous 5,479
-0.0%
Holding current value
$534,257
Previous $489,000
6.13%
% of portfolio
0.07%
Previous 0.12%
Shares
15 transactions
Others Institutions Holding XBI
# of Institutions
922Shares Held
99.9MCall Options Held
24.7MPut Options Held
43.4M-
Goldman Sachs Group Inc New York, NY9.88MShares$964 Million0.17% of portfolio
-
Citigroup Inc8.82MShares$860 Million0.56% of portfolio
-
Jpmorgan Chase & CO New York, NY7.85MShares$765 Million0.07% of portfolio
-
Bank Of America Corp Charlotte, NC7.64MShares$745 Million0.07% of portfolio
-
Morgan Stanley New York, NY7.3MShares$712 Million0.06% of portfolio